In addition to being a histone deacetylase (HDAC) inhibitor, butyrate is also known to activate the GPCRs GPR43 (FFA2), GPR41 (FFA3), and GPR109A, which are expressed in RA-relevant immune cells and mediate anti-inflammatory responses [73]. Here, HCAR2 is linked to rheumatoid arthritis.